Similarly, bone mineral disorders, altered fibroblast growth factor 23 (FGF23), low vitamin-D levels and hyperphosphatemia all impinge upon microvascular dysfunction, thereby triggering or worsening subclinical atherosclerosis [21]. Here, FGF23 is linked to abnormal mineralization disorder.